These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3458)

  • 1. The effects of some polypeptides on the systemic blood pressure of sheep (author's transl).
    Ormas P; Pompa G; Beretta C; Faustini R
    Folia Vet Lat; 1975; 5(1):45-54. PubMed ID: 3458
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison in conscious and anaesthetized dogs of the effect on blood pressure of bradykinin, kallidin, eledoisin and kallikrein.
    Pearson L; Lang WJ
    Eur J Pharmacol; 1967 Nov; 2(2):83-7. PubMed ID: 5583434
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of the intraventricular administration of angiotensin II, bradykinin and eledoisin on the arterial blood pressure, respiratory movements and electrocardiogram.
    Cuparencu B; Ticşa I; Safta L; Csutak V; Mocan R
    Rev Roum Physiol; 1969; 6(3):213-20. PubMed ID: 4323315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of various polypeptides on the motility of the omasum in ruminants].
    Faustini R
    Dtsch Tierarztl Wochenschr; 1976 May; 83(5):192-4. PubMed ID: 776562
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of physalaemin on the systemic arterial blood pressure of some experimental animals.
    Bertaccini G; Cei JM; Erspamer V
    Br J Pharmacol Chemother; 1965 Oct; 25(2):380-91. PubMed ID: 4286324
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vascular effect of eledoisin and cerulein in man and animals].
    Glässer AH
    Boll Chim Farm; 1972 May; 111(5):284-92. PubMed ID: 4340558
    [No Abstract]   [Full Text] [Related]  

  • 7. [On neurally facilitated circulatory effects of bradykinin and eledoisin].
    Felix W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):16-7. PubMed ID: 4231834
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bradykinin on the urokinase excretion in rabbits.
    Hamberg U; Savolainen ML
    Scand J Clin Lab Invest Suppl; 1969; 107():105-12. PubMed ID: 5375719
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clenbuterol: a new partial antagonist of the beta adrenergic receptors (author's transl)].
    Morales-Olivas FJ; Brugger AJ; Bedate H; García-Díez JM; Morcillo E; Esplugues J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):131-8. PubMed ID: 6110409
    [No Abstract]   [Full Text] [Related]  

  • 10. Biogenic amines and active polypeptides of the amphibian skin.
    Erspamer V
    Annu Rev Pharmacol; 1971; 11():327-50. PubMed ID: 4948501
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandins and renal function.
    McGiff JC; Crowshaw K; Itskovitz HD
    Fed Proc; 1974 Jan; 33(1):39-47. PubMed ID: 4359037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peptide receptors for tachykinins in the human Fallopian tube].
    Zetler G; Mönkemeier D; Wiechell H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):97-111. PubMed ID: 4237045
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom.
    Ferreira SH; Rocha e Silva M
    Experientia; 1965 Jun; 21(6):347-9. PubMed ID: 5870517
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetische Polypeptide (Bradykinin, Kallidin, Eledoisin) und die Bakterien-Phagozytose der Leukozyten.
    Ludány G; Vajda J; Bertha I
    Acta Physiol Acad Sci Hung; 1967; 32(3):267-73. PubMed ID: 6080189
    [No Abstract]   [Full Text] [Related]  

  • 15. Active polypeptides of nonmammalian origin.
    Bertaccini G
    Pharmacol Rev; 1976 Jun; 28(2):127-77. PubMed ID: 794887
    [No Abstract]   [Full Text] [Related]  

  • 16. The action of caerulein on the systemic arterial blood pressure of some experimental animals.
    Bertaccini G; De Caro G; Endean R; Erspamer V; Impicciatore M
    Br J Pharmacol Chemother; 1968 May; 33(1):59-71. PubMed ID: 5660166
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and haemodynamic effects of eledoisin and physalaemin with special references to peripheral circulation.
    Borghetti A; Ferrari S; La Greca G; Minardi E; Novarini A
    Angiologica; 1966; 3(3):168-76. PubMed ID: 5936215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
    Ishihara T; Watanabe K; Takenaka F
    Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuromorphological reactions in the human skin towards bradykinin, eledoisin-like substance and physalaemin. I. (Observation on the peripheral nerve)].
    Okumura Y; Kawazu T; Matsuda H
    Arerugi; 1969 Jun; 18(6):518-9. PubMed ID: 5823238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.